Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammerhead ribozyme

Molecular Endocrinology

Volumn 12, Issue 10, 1998, Pages 1558-1566

  Chen, S ^a   Song, C S ^a   Lavrovsky, Y ^a   Bi, B ^a   Vellanoweth, R ^a   Chatterjee, B ^a   Roy, A K ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CHLORAMPHENICOL ACETYLTRANSFERASE; ENDONUCLEASE; MESSENGER RNA; RIBOZYME;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL GROWTH; ENZYME ACTIVITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HORMONAL REGULATION; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; KINETICS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; RAT; REPORTER GENE;

ANIMALIA; FELIS CATUS;

EID: 0032230278     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.12.10.0186     Document Type: Article

References (45)

1. The nuclear receptor superfamily: The second decade
2. Transcriptional activation and nuclear targeting signals of the human androgen receptor
3. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators
4. Regulation of androgen action
5. Management of cancer of the prostate
6. Ribozymes: A distinct class of metalloenzymes
7. Simple RNA enzymes with new and highly specific endoribonuclease activities
8. Ribozyme therapeutics
9. Selection of hammerhead ribozymes for optimum cleavage of interleukin 6 mRNA
10. How does the 2'hydroxy group drive the pseudorotational equilibrium in nucleoside and nucleotide by the tuning of 3'-gauche effect
11. Ribozymes as potential anti-HIV-1 therapeutic agents
12. Reversal of the malignant phenotype by an anti-ras ribozyme
13. Generating loss-of-function phenotypes of the fushi tarazu gene with a targeted ribozyme in Drosophila
14. A ribozyme-mediated, gene 'knockdown' strategy for the identification of gene function in zebrafish
15. On finding all suboptimal foldings of an RNA molecule
16. Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb
17. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors
18. A general purpose RNA-cleaving DNA enzyme
19. A fast and accurate enzyme-linked immunosorbent assay for the determination of the DNA cleavage activity of restriction endonucleases
20. Establishment and characterization of monoclonal antibody against androgen receptor
21. Therapeutic potential and mechanism of action of oligonucleotides and ribozymes
22. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein
23. In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNA
24. Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer
25. HER-2/neu is rate-limiting for ovarian cancer growth. Conditional depletion of HER-2/neu by ribozyme targeting
26. Efficient and specific ribozyme-mediated reduction of bovine alpha- lactalbumin expression in double transgenic mice
27. Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library
28. A stable hammerhead structure is not required for endonucleolytic activity of a ribozyme in vivo
29. Substrate sequence effects on 'hammerhead' RNA catalytic efficiency
30. Catalysis of RNA cleavage by the Tetrahymena thermophila ribozyme. 1. Kinetic description of the reaction of an RNA substrate complementary to the active site
31. In vivo decay kinetic parameters of hammerhead ribozymes
32. Inhibition of fatty acid synthesis by expression of an acetyl-CoA carboxylase-specific ribozyme gene
33. Specific gene suppression by engineered ribozymes in monkey cells
34. Ribozyme mediated destruction of RNA in vivo
35. Messenger RNA degradation in eukaryotes
36. Antisense oligodeoxyribonucleotides suppress hematologic ceil growth through stepwise release of deoxyribonucleotides
37. Treatment of progressive metastatic prostate cancer
38. In vivo amplification of the androgen receptor gene and progression of human prostate cancer
39. Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer
40. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation
41. Androgen receptor activation in prostatic tumor cell lines by insulin like growth factor-l, keratinocyte growth factor, and epidermal growth factor
42. Activation of the human androgen receptor through a protein kinase A signaling pathway
43. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
44. Inhibition of human immunodeficiency virus type I expression by a hairpin ribozyme
45. Testosterone up-regulates androgen receptors and decreases differentiation of porcine myogenic satellite cells in vitro